Filing Details

Accession Number:
0001140361-10-025044
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-10 13:00:00
Reporting Period:
2010-06-08
Filing Date:
2010-06-10
Accepted Time:
2010-06-10 13:36:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1211583 Adherex Technologies Inc ADHXF Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1319998 Southpoint Capital Advisors Lp 623 Fifth Avenue
Suite 2601
New York NY 10022
No No Yes No
1378376 Southpoint Gp, Lp 623 Fifth Avenue, Suite 2601
New York NY 10022
No No Yes No
1378377 Southpoint Capital Advisors Llc 623 Fifth Avenue, Suite 2601
New York NY 10022
No No Yes No
1378378 Southpoint Gp, Llc 623 Fifth Avenue, Suite 2601
New York NY 10022
No No Yes No
1378379 Ii Smith John Clark 623 Fifth Avenue, Suite 2601
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-06-08 41,504,000 $0.00 200,000,000 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Disposition 2010-06-08 41,504,000 $0.00 41,504,000 $0.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
158,496,000 2010-10-30 2015-04-30 No 4 S Indirect
Footnotes
  1. The reported securities are included within 41,504,000 units sold by the reporting persons for CDN$0.03 per unit. Each unit consists of one share of common stock of Adherex Technologies Inc. and one warrant to purchase one share of common stock of Adherex Technologies Inc.
  2. Southpoint Capital Advisors LP, and its general partner Southpoint Capital Advisors LLC, hold the reported securities indirectly on behalf of Southpoint Fund LP, Southpoint Qualified Fund LP, Southpoint Master Fund, LP and Southpoint Offshore Fund, Ltd., for which Southpoint Capital Advisors LP serves as investment manager. Southpoint GP, LP, and its general partner Southpoint GP, LLC, hold the reported securities indirectly on behalf of Southpoint Fund LP, Southpoint Qualified Fund LP, and Southpoint Master Fund, LP, of which Southpoint GP, LP is the general partner. John S. Clark II reports the securities held indirectly by Southpoint GP, LLC and Southpoint Capital Advisors LLC as the manager of each.
  3. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  4. The exercise price of the warrants reported is listed in Canadian Dollars.